clinical trial · NCT00417937
A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily
LEO Pharma·phase4·completed·n = 98
Papulopustular Rosaceaazelaic acid 15% gelazelaic acid 15% gel
brief summary
To assess the efficacy and tolerability of azelaic acid 15% gel applied once daily versus twice daily in the treatment of patients with papulopustular rosacea.
started
Jan 1, 2007
primary completion
Jun 1, 2007
completion
Jun 1, 2007
last updated
Jun 9, 2023
detailed description
To test the efficacy and safety of once vs twice daily application of azelaic acid 15% gel on papulopustular rosacea
official title
A Multicenter, Double-Blind Clinical Trial to Assess the Efficacy and Tolerability of Topical Azelaic Acid 15% Gel Once Daily Compared to Topical Azelaic Acid 15% gelTwice Daily in Subjects With Papulopustular Rosacea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol